|
[1]Kisseleva T, Gigante E, Brenner DA.Recent advances in liv-er stem cell therapy[J].Curr Opin Gastroenterol, 2010, 26 (4) :395-402.
|
|
[2]BasmaH, Soto-Gutierrez A, Yannam GR, et al.Differentia-tion and transplantation of human embryonic stem cell-de-rived hepatocytes[J].Gastroenterology, 2009, 136:990-999.
|
|
[3] Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line[J]. Liver Transpl, 2010, 16 (2) : 118-129.
|
|
[4]Tajima F, Tsuchiya H, Nishikawa K, et al.Hepatocyte growthfactor mobilizes and recruits hematopoietic progenitor cells intoliver through astem cellfactor-mediatedmechanism[J].Hep-atol Res, 2010, 40 (7) :711-719.
|
|
[5]Aurich H, SgoddaM, Kaltwasser P, et al.Hepatocyte differ-entiation of mesenchymal stem cells from human adipose tis-sue in vitro promotes hepatic integration in vivo[J].Gut, 2009, 58 (4) :570-581.
|
|
[6]Yagi H, Parekkadan B, Suganuma K, et al.Long-term su-perior performance of a stem cell/hepatocyte device for thetreatment of acute liver failure[J].Tissue Eng Part A, 2009, 15 (11) :3377-3388.
|
|
[7]Banas A, Teratani T, Yamamoto Y, et al.Rapid hepatic fatespecification of adipose-derived stem cells and their thera-peutic potential for liver failure[J].J Gastroenterol Hepatol, 2009, 24 (1) :70-77.
|
|
[8]Kharaziha P, Hellstrim PM, Noorinayer B, et al.Improve-ment of liver function in liver cirrhosis patients after autolo-gous mesenchymal stem cell injection:a phase I-II clinicaltrial[J].Eur J Gastroenterol Hepatol, 2009, 21 (10) :1199-1205.
|
|
[9] Ramasamy R, Lam EW, Soeiro I, et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth[J]. Leukemia, 2007, 21 (2) : 3040-310.
|
|
[10]Alberti E, Los M, GarciaR, et al.Prolonged survival and ex-pression of neural markers by bone marrow derived stemcells transplanted into brain lesions[J].Med Sci Munit, 2009, 15 (2) :BR47-54.
|
|
[11]Hu J, Feng K, Liu X, et al.Chondrogenic and osteogenicdifferentiations of human bone marrow-derived mesenchy-ma1 stem cells on ananofibrous scaffold with designed porenetwork[J].Biomaterials, 2009, 30 (28) :5061-5067.
|
|
[12]Chivu M, Dima SO, Stancu CI, et al.In vitro hepatic differ-entiation of human bone marrow mesenchymal stem cellsunder differential exposure to liver specific factors[J].TranslRes, 2009, 154 (3) :122-132.
|
|
[13]Bonora-Centelles A, Jover R, Mirabet V, et al.Sequentialhepatogenic trans-diferentiation of adipose tissue-derivedstem cells:relevance of different extracellular signaling mole-cules, transcription factors involved and expression of newkey marker genes[J].Cell Transplant, 2009, 18 (12) :1319-1340.
|
|
[14] Quintana-Bustamante O, Alvarez-Barrientos A, Kofman AV, et al. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion[J]. Hepatology, 2006, 43 (1) : 108-116.
|
|
[15]Sato Y, Araki H, Kato J, et al.Human mesenchymal stemcells xenografted directly to rat liver are differentiated into hu-man hepatocytes without fusion[J].Blood, 2005, 106 (2) :756-763.
|
|
[16]Van Poll D, Parekkadan B, Cho CH, et al.Mesenchymalstem cell-derived molecules directly modulate hepatocellu-lar death and regeneration in vitro and in vivo[J].Hepatolo-gy, 2008, 47 (5) :1634-1643.
|
|
[17] Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy in liver disease: parameters governing the success of using bone marrow mesenchymal stem cells[J]. Gastrenterology , 2008, 134 (7) : 2111-2121.
|
|
[18] Kim WH, Matsumoto K, Bessho K, et al. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis[J]. Am J Pathol, 2005, 166 (7) : 1017-1028.
|
|
[19]Carvalho AB, Quintanilha LF, Dias JV, et al.Bone marrowmultipotent mesenchymal stromal cells do not reduce fibrosisor improve function in arat model of severe chronic liver inju-ry[J].Stem Cells, 2008, 26:1307-1314.
|
|
[20]Chen Z, Qi LZ, Zeng R, et al.Stem cells and hepatic cirrho-sis[J].Panminerva Med, 2010, 52 (2) :149-165.
|
DownLoad: